Pacemakers
Adapta™ pacemaker
Pacemakers
Adapta™ pacemaker
The Adapta™ pacing system includes pacing with automaticity.
Description
With managed ventricular pacing (MVP™) to pace less
Adapta™ DR is the first pacemaker with managed ventricular pacing (MVP™) technology, which reduces unnecessary right ventricular pacing by 99%.1 Reducing unnecessary ventricular pacing has been shown to improve clinical outcomes by reducing the risks of atrial fibrillation (AF)2–5 and heart failure hospitalization (HFH).2,5
Ordering information
| Item number | Description | Volume (mL) | Size — height × width × depth (mm) |
Connector | Battery type / voltage |
|---|---|---|---|---|---|
| ADDR03 | Adapta™ DR | 13.0 | 46.7 × 47.9 × 7.5 | 3.2 mm LP BI, IS-1 BI, or UNI | Lithium-iodine / 2.8V |
| ADDR06 | Adapta™ DR | 14.2 | 50.3 × 47.9 × 7.5 | 5 or 6 mm UNIa | Lithium-iodine / 2.8V |
| ADVDD01 | Adapta™ VDD | 11.1 | 44.7 × 42.9 × 7.5 | IS-1 BI or UNI | Lithium-iodine / 2.8V |
| ADSR03 | Adapta™ SR | 10.5 | 42.9 × 42.9 × 7.5 | 3.2 mm LP BI, IS-1 BI, or UNI | Lithium-iodine / 2.8V |
| ADSR06 | Adapta™ SR | 11.0 | 43.3 × 42.9 × 7.5 | 5 or 6 mm UNI† | Lithium-iodine / 2.8V |
† Parylene coating on backside of case
Similar products
-
Astra™ MRI SureScan™ pacemakerThe Astra™ MRI SureScan™ pacemaker features single- and dual-chamber options.
-
Attesta™ MRI SureScan™ pacemakerThe Attesta™ MRI SureScan™ pacemaker is used for bradyarrhythmia management.
-
Azure™ MRI SureScan™ pacemakerThe Azure™ MRI SureScan™ pacemaker manages atrial fibrillation (AF) in pacemaker patients with tablet-based programming and app-based remote monitoring.
-
Micra™ AV2 leadless pacemakerMicra™ AV2 provides an unmatched leadless pacing experience for patients with bradycardia.
-
Micra™ VR2 leadless pacemakerMicra™ VR2 provides an unmatched leadless pacing experience for patients with bradycardia.
-
Sphera™ MRI SureScan™ pacing systemThe Sphera MRI™ SureScan™ pacemaker allows for programming at implant and follow-up.
- Gillis A, Pürerfellner H, Israel C, et al. Reduction of unnecessary ventricular pacing due to the managed ventricular pacing (MVP) mode in pacemaker patients: Benefit for both sinus node disease (SND) and AV block (AVB) indications. Presented at HRS 2005 (Abstract AB21-1).
- Anderson HR, et al. Lancet. 1997;350:1210–1216.
- Skanes AC, et al. J Am Coll Cardiol. 2001;38:167–172.
- Neilsen J, et al. J Am Coll Cardiol. 2003;42:614–623.
- Sweeney M, et al. Circulation. 2003;107:2932–2937.
This product is licenced with Health Canada as "SINGLE AND DUAL CHAMBER RATE RESPONSIVE PACEMAKERS" on Health Canada licence number "MDL#69537 ".